High-efficiency photothermal preparations are manufactured with materials with high photothermal conversion efficiency as raw materials, and are used in various forms of preparations for the prevention, treatment and diagnosis of corresponding physiological symptoms of the human body.
The global High-efficiency Photothermal Preparation market is projected to reach US$ 67 million in 2029, increasing from US$ 36 million in 2022, with the CAGR of 7.7% during the period of 2023 to 2029.
High-efficiency photothermal preparations can efficiently convert laser energy into heat energy to heat the tumor site. . This is a minimally invasive technology that has been used to treat various cancers and other diseases, and has great potential in medical treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global High-efficiency Photothermal Preparation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
NanoComposix
Siva Therapeutics
Segment by Type
Dosage Form for Gastrointestinal Administration
Dosage Form for Parenteral Administration
Segment by Application
Benign Tumor Treatment
Malignant Tumor Treatment
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The High-efficiency Photothermal Preparation report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Âé¶¹Ô´´ Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Âé¶¹Ô´´ Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global High-efficiency Photothermal Preparation Âé¶¹Ô´´ Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Dosage Form for Gastrointestinal Administration
1.2.3 Dosage Form for Parenteral Administration
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global High-efficiency Photothermal Preparation Âé¶¹Ô´´ Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Benign Tumor Treatment
1.3.3 Malignant Tumor Treatment
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global High-efficiency Photothermal Preparation Âé¶¹Ô´´ Perspective (2018-2029)
2.2 High-efficiency Photothermal Preparation Growth Trends by Region
2.2.1 Global High-efficiency Photothermal Preparation Âé¶¹Ô´´ Size by Region: 2018 VS 2022 VS 2029
2.2.2 High-efficiency Photothermal Preparation Historic Âé¶¹Ô´´ Size by Region (2018-2023)
2.2.3 High-efficiency Photothermal Preparation Forecasted Âé¶¹Ô´´ Size by Region (2024-2029)
2.3 High-efficiency Photothermal Preparation Âé¶¹Ô´´ Dynamics
2.3.1 High-efficiency Photothermal Preparation Industry Trends
2.3.2 High-efficiency Photothermal Preparation Âé¶¹Ô´´ Drivers
2.3.3 High-efficiency Photothermal Preparation Âé¶¹Ô´´ Challenges
2.3.4 High-efficiency Photothermal Preparation Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top High-efficiency Photothermal Preparation Players by Revenue
3.1.1 Global Top High-efficiency Photothermal Preparation Players by Revenue (2018-2023)
3.1.2 Global High-efficiency Photothermal Preparation Revenue Âé¶¹Ô´´ Share by Players (2018-2023)
3.2 Global High-efficiency Photothermal Preparation Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by High-efficiency Photothermal Preparation Revenue
3.4 Global High-efficiency Photothermal Preparation Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global High-efficiency Photothermal Preparation Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by High-efficiency Photothermal Preparation Revenue in 2022
3.5 High-efficiency Photothermal Preparation Key Players Head office and Area Served
3.6 Key Players High-efficiency Photothermal Preparation Product Solution and Service
3.7 Date of Enter into High-efficiency Photothermal Preparation Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 High-efficiency Photothermal Preparation Breakdown Data by Type
4.1 Global High-efficiency Photothermal Preparation Historic Âé¶¹Ô´´ Size by Type (2018-2023)
4.2 Global High-efficiency Photothermal Preparation Forecasted Âé¶¹Ô´´ Size by Type (2024-2029)
5 High-efficiency Photothermal Preparation Breakdown Data by Application
5.1 Global High-efficiency Photothermal Preparation Historic Âé¶¹Ô´´ Size by Application (2018-2023)
5.2 Global High-efficiency Photothermal Preparation Forecasted Âé¶¹Ô´´ Size by Application (2024-2029)
6 North America
6.1 North America High-efficiency Photothermal Preparation Âé¶¹Ô´´ Size (2018-2029)
6.2 North America High-efficiency Photothermal Preparation Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America High-efficiency Photothermal Preparation Âé¶¹Ô´´ Size by Country (2018-2023)
6.4 North America High-efficiency Photothermal Preparation Âé¶¹Ô´´ Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe High-efficiency Photothermal Preparation Âé¶¹Ô´´ Size (2018-2029)
7.2 Europe High-efficiency Photothermal Preparation Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe High-efficiency Photothermal Preparation Âé¶¹Ô´´ Size by Country (2018-2023)
7.4 Europe High-efficiency Photothermal Preparation Âé¶¹Ô´´ Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific High-efficiency Photothermal Preparation Âé¶¹Ô´´ Size (2018-2029)
8.2 Asia-Pacific High-efficiency Photothermal Preparation Âé¶¹Ô´´ Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific High-efficiency Photothermal Preparation Âé¶¹Ô´´ Size by Region (2018-2023)
8.4 Asia-Pacific High-efficiency Photothermal Preparation Âé¶¹Ô´´ Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America High-efficiency Photothermal Preparation Âé¶¹Ô´´ Size (2018-2029)
9.2 Latin America High-efficiency Photothermal Preparation Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America High-efficiency Photothermal Preparation Âé¶¹Ô´´ Size by Country (2018-2023)
9.4 Latin America High-efficiency Photothermal Preparation Âé¶¹Ô´´ Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa High-efficiency Photothermal Preparation Âé¶¹Ô´´ Size (2018-2029)
10.2 Middle East & Africa High-efficiency Photothermal Preparation Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa High-efficiency Photothermal Preparation Âé¶¹Ô´´ Size by Country (2018-2023)
10.4 Middle East & Africa High-efficiency Photothermal Preparation Âé¶¹Ô´´ Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NanoComposix
11.1.1 NanoComposix Company Detail
11.1.2 NanoComposix Business Overview
11.1.3 NanoComposix High-efficiency Photothermal Preparation Introduction
11.1.4 NanoComposix Revenue in High-efficiency Photothermal Preparation Business (2018-2023)
11.1.5 NanoComposix Recent Development
11.2 Siva Therapeutics
11.2.1 Siva Therapeutics Company Detail
11.2.2 Siva Therapeutics Business Overview
11.2.3 Siva Therapeutics High-efficiency Photothermal Preparation Introduction
11.2.4 Siva Therapeutics Revenue in High-efficiency Photothermal Preparation Business (2018-2023)
11.2.5 Siva Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
NanoComposix
Siva Therapeutics
Ìý
Ìý
*If Applicable.